Full name
APTEKA REMEDIUM BAMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA JAWNA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 41,2 | |||
Gross profit (loss) | 0,1 | 0,1 | 0,1 | -60,1 |
EBITDA | 27,3 | |||
Short time liabilities | 28,5 | |||
Income tax | 0 | 0 | 0 | -100 |
Other operating costs | 75,4 | |||
Equity capital | 0,2 | 0,3 | 0,2 | -27,6 |
Operating profit (EBIT) | 33,4 | |||
Assets | 0,8 | 0,9 | 0,8 | -3,1 |
Net profit (loss) | 0,1 | 0,1 | 0,1 | -60,1 |
Cash | -54,7 | |||
Net income from sale | 2,6 | |||
Liabilities and provisions for liabilities | 0,6 | 0,6 | 0,6 | 10,9 |
Working assets | 0,8 | 0,9 | 0,8 | -2,8 |
Other income costs | -69,8 | |||
Basic operational activity income | 2,7 | 3,1 | 3,2 | 2,7 |
Depreciation | 6,3 | |||
% | % | % | p.p. | |
Profitability of capital | 29,6 | 46 | 25,4 | -20,6 |
Equity capital to total assets | 29,2 | 36,2 | 27 | -9,2 |
Gross profit margin | 2,6 | 4,7 | 1,8 | -2,9 |
EBITDA Margin | 0,6 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 17 | |||
Current financial liquidity indicator | 0 | |||
Net dept to EBITDA | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane